HHS HARTE HANKS INC revenue, earnings and financials
For the quarter ended June 30, 2026, HARTE HANKS INC reported revenue of $38.0M (down 1.7% from a year earlier), net income of −$5.00M and diluted EPS of −$0.67; over the last four quarters revenue was $155M and net income −$5.72M; for the fiscal year ended December 2025 revenue was $160M, down 13.9% on the year before.
HHS annual revenue and earnings
- Fiscal year ended Dec 2025: revenue $160M, gross profit n/a, operating income $386K, net income −$811K (margin -0.5%), EPS −$0.11
- Fiscal year ended Dec 2024: revenue $185M, gross profit n/a, operating income $2.09M, net income −$811K (margin -0.4%), EPS −$4.15
- Fiscal year ended Dec 2023: revenue $191M, gross profit n/a, operating income $3.36M, net income −$30.3M (margin -15.8%), EPS −$0.21
- Fiscal year ended Dec 2022: revenue $206M, gross profit n/a, operating income $15.1M, net income −$1.57M (margin -0.8%), EPS $4.75
- Fiscal year ended Dec 2021: revenue $195M, gross profit n/a, operating income $7.64M, net income $15.0M (margin 7.7%), EPS $1.76
HHS quarterly revenue and earnings
- Quarter ended Jun 30, 2026: revenue $38.0M (down 1.7% year over year), net income −$5.00M, EPS −$0.67
- Quarter ended Mar 31, 2026: revenue $37.3M (down 10.3% year over year), net income −$628K, EPS −$0.08
- Quarter ended Dec 31, 2025 (from the annual report): revenue $39.9M (down 15.4% year over year), net income $2.20M, EPS $0.30
- Quarter ended Sep 30, 2025: revenue $39.5M (down 17.0% year over year), net income −$2.29M, EPS −$0.31
- Quarter ended Jun 30, 2025: revenue $38.6M (down 14.2% year over year), net income −$335K, EPS −$0.05
- Quarter ended Mar 31, 2025: revenue $41.6M (down 8.6% year over year), net income −$392K, EPS −$0.05
- Quarter ended Dec 31, 2024 (from the annual report): revenue $47.1M (down 4.8% year over year), net income $27.1M, EPS −$0.31
- Quarter ended Sep 30, 2024: revenue $47.6M (up 1.1% year over year), net income $142K, EPS $0.02
- Quarter ended Jun 30, 2024: revenue $45.0M (down 5.7% year over year), net income −$27.8M, EPS −$3.84
- Quarter ended Mar 31, 2024: revenue $45.4M (down 3.5% year over year), net income −$171K, EPS −$0.02
- Quarter ended Dec 31, 2023 (from the annual report): revenue $49.5M (down 9.7% year over year), net income −$30.7M, EPS −$0.26
- Quarter ended Sep 30, 2023: revenue $47.1M (down 12.6% year over year), net income $618K, EPS $0.08
- Quarter ended Jun 30, 2023: revenue $47.8M (down 1.6% year over year), net income $580K, EPS $0.08
- Quarter ended Mar 31, 2023: revenue $47.1M (down 4.0% year over year), net income −$791K, EPS −$0.11
- Quarter ended Dec 31, 2022 (from the annual report): revenue $54.8M (up 5.4% year over year), net income −$16.5M, EPS $3.01
- Quarter ended Sep 30, 2022: revenue $53.9M (up 8.6% year over year), net income $7.17M, EPS $0.83
- Quarter ended Jun 30, 2022: revenue $48.6M (down 1.4% year over year), net income $4.46M, EPS $0.52
- Quarter ended Mar 31, 2022: revenue $49.1M (up 12.1% year over year), net income $3.35M, EPS $0.39
- Quarter ended Dec 31, 2021 (from the annual report): revenue $52.0M, net income $1.76M, EPS $0.25
- Quarter ended Sep 30, 2021: revenue $49.6M, net income $4.40M, EPS $0.52
HHS cash flow, buybacks and dividends
- Fiscal year ended Dec 2025: operating cash flow −$1.74M, share buybacks n/a
- Fiscal year ended Dec 2024: operating cash flow −$2.99M, share buybacks $0
- Fiscal year ended Dec 2023: operating cash flow $10.5M, share buybacks $2.37M
- Fiscal year ended Dec 2022: operating cash flow $28.8M, share buybacks $0
- Fiscal year ended Dec 2021: operating cash flow −$1.76M, share buybacks n/a
HHS balance sheet
- Jun 30, 2026: cash $5.19M, total assets $88.1M, total liabilities $72.7M, shareholders' equity $15.4M
- Mar 31, 2026: cash $4.53M, total assets $90.4M, total liabilities $70.3M, shareholders' equity $20.1M
- Dec 31, 2025: cash $5.58M, total assets $91.8M, total liabilities $71.3M, shareholders' equity $20.5M
- Sep 30, 2025: cash $6.51M, total assets $92.7M, total liabilities $72.8M, shareholders' equity $19.9M
- Jun 30, 2025: cash $4.68M, total assets $95.0M, total liabilities $72.8M, shareholders' equity $22.2M
- Mar 31, 2025: cash $8.71M, total assets $101M, total liabilities $79.2M, shareholders' equity $21.4M
- Dec 31, 2024: cash $9.81M, total assets $102M, total liabilities $80.1M, shareholders' equity $21.7M
- Sep 30, 2024: cash $5.94M, total assets $108M, total liabilities $87.1M, shareholders' equity $21.0M
What is HHS's revenue?
HARTE HANKS INC reported $155M of revenue over its last four quarters, through June 30, 2026.
Is HHS profitable?
No. HARTE HANKS INC lost $5.72M over the last four quarters.
What is HHS's EPS?
Diluted earnings per share over the last four quarters were −$0.76; −$0.67 in the latest quarter.